Intravenous immunoglobulin is a blood product used for intravenous injection, and its effect can last for 2 weeks to 3 months after injection. It is a non-specific gamma immunoglobulin extracted from plasma donated by thousands of blood donors and gathered together. Mainly used in the following three major scenarios: Immune deficiencies such as: sex-linked genetic agammaglobulinemia, hypogammaglobulinemia, and acquired immune decline diseases that lead to low antibody levels
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Intravenous Immune Globulin Therapies industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Liquid Form
Lyophilized Powder Form
Market Segment by Product Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Finally, the report provides detailed profile and data information analysis of leading company.
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Intravenous Immune Globulin Therapies consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Intravenous Immune Globulin Therapies market by identifying its various subsegments.
3.Focuses on the key global Intravenous Immune Globulin Therapies manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Intravenous Immune Globulin Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Intravenous Immune Globulin Therapies submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Intravenous Immune Globulin Therapies Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Intravenous Immune Globulin Therapies Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Intravenous Immune Globulin Therapies Segment by Type
2.1.1 Liquid Form
2.1.2 Lyophilized Powder Form
2.2 Market Analysis by Application
2.2.1 Immunodeficiency
2.2.2 Autoimmune Disease
2.2.3 Acute Infection
2.3 Global Intravenous Immune Globulin Therapies Market Comparison by Regions (2017-2027)
2.3.1 Global Intravenous Immune Globulin Therapies Market Size (2017-2027)
2.3.2 North America Intravenous Immune Globulin Therapies Status and Prospect (2017-2027)
2.3.3 Europe Intravenous Immune Globulin Therapies Status and Prospect (2017-2027)
2.3.4 China Intravenous Immune Globulin Therapies Status and Prospect (2017-2027)
2.3.5 Japan Intravenous Immune Globulin Therapies Status and Prospect (2017-2027)
2.3.6 Southeast Asia Intravenous Immune Globulin Therapies Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Intravenous Immune Globulin Therapies Industry Impact
2.5.1 Intravenous Immune Globulin Therapies Business Impact Assessment - Covid-19
2.5.2 Market Trends and Intravenous Immune Globulin Therapies Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Intravenous Immune Globulin Therapies Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Intravenous Immune Globulin Therapies Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Intravenous Immune Globulin Therapies Manufacturer Market Share
3.5 Top 10 Intravenous Immune Globulin Therapies Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Intravenous Immune Globulin Therapies Market
3.7 Key Manufacturers Intravenous Immune Globulin Therapies Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Intravenous Immune Globulin Therapies Industry Key Manufacturers
4.1 Baxter
4.1.1 Compan Detail
4.1.2 Baxter Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.1.3 Baxter 131 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Baxter News
4.2 Grifols
4.2.1 Compan Detail
4.2.2 Grifols Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.2.3 Grifols Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Baxter News
4.3 CSL Plasma
4.3.1 Compan Detail
4.3.2 CSL Plasma Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.3.3 CSL Plasma Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 CSL Plasma News
4.4 Octapharma
4.4.1 Compan Detail
4.4.2 Octapharma Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.4.3 Octapharma Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Octapharma News
4.5 Biotest
4.5.1 Compan Detail
4.5.2 Octapharma Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.5.3 Biotest Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Biotest News
4.6 Kedrion
4.6.1 Compan Detail
4.6.2 Kedrion Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.6.3 Kedrion Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Kedrion News
4.7 Kamada
4.7.1 Compan Detail
4.7.2 Kamada Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.7.3 Kamada Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 China Biologic Products Holdings
4.8.1 Compan Detail
4.8.2 China Biologic Products Holdings Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 China Biologic Products Holdings News
4.9 Hualan Biological Engineering
4.9.1 Compan Detail
4.9.2 Hualan Biological Engineering Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Hualan Biological Engineering News
4.10 Sichuan Yuanda Shuyang Pharmaceutical
4.10.1 Compan Detail
4.10.2 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product Introduction, Application and Specification
4.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Sichuan Yuanda Shuyang Pharmaceutical News
5 Global Intravenous Immune Globulin Therapies Market Segment by Big Type
5.1 Global Intravenous Immune Globulin Therapies Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Intravenous Immune Globulin Therapies Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Intravenous Immune Globulin Therapies Revenue and Market Share by Big Type (2017-2022)
5.2 Liquid Form Sales Growth Rate and Price
5.2.1 Global Liquid Form Sales Growth Rate (2017-2022)
5.2.2 Global Liquid Form Price (2017-2022)
5.3 Lyophilized Powder Form Sales Growth Rate and Price
5.3.1 Global Lyophilized Powder Form Sales Growth Rate (2017-2022)
5.3.2 Global Lyophilized Powder Form Price (2017-2022)
6 Global Intravenous Immune Globulin Therapies Market Segment by Big Application
6.1 Global Intravenous Immune Globulin Therapies Sales Market Share by Big Application (2017-2022)
6.2 Immunodeficiency Sales Growth Rate (2017-2022)
6.3 Autoimmune Disease Sales Growth Rate (2017-2022)
6.4 Acute Infection Sales Growth Rate (2017-2022)
7 Global Intravenous Immune Globulin Therapies Forecast
7.1 Global Intravenous Immune Globulin Therapies Revenue, Sales and Growth Rate (2022-2027)
7.2 Intravenous Immune Globulin Therapies Market Forecast by Regions (2022-2027)
7.2.1 North America Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
7.2.2 Europe Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
7.2.3 China Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
7.2.4 Japan Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
7.2.5 Southeast Asia Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
7.2.6 Other Regions Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
7.3 Intravenous Immune Globulin Therapies Market Forecast by Type (2022-2027)
7.3.1 Global Intravenous Immune Globulin Therapies Sales Forecast by Type (2022-2027)
7.3.2 Global Intravenous Immune Globulin Therapies Market Share Forecast by Type (2022-2027)
7.4 Intravenous Immune Globulin Therapies Market Forecast by Application (2022-2027)
7.4.1 Global Intravenous Immune Globulin Therapies Sales Forecast by Application (2022-2027)
7.4.2 Global Intravenous Immune Globulin Therapies Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Intravenous Immune Globulin Therapies Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Intravenous Immune Globulin Therapies Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Intravenous Immune Globulin Therapies
Figure Market Concentration Ratio and Market Maturity Analysis of Intravenous Immune Globulin Therapies
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Intravenous Immune Globulin Therapies Market Size by Big Type
Figure Global Market Share of Intravenous Immune Globulin Therapies by Big Type in 2021
Figure Liquid Form Picture (2017-2022)
Global Intravenous Immune Globulin Therapies Market Size by Big Application
Table Global Intravenous Immune Globulin Therapies Market Size by Application
Figure Global Intravenous Immune Globulin Therapies Market Share by Big Application in 2021
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Table Global Intravenous Immune Globulin Therapies Comparison by Regions (M USD) (2017-2027)
Figure Global Intravenous Immune Globulin Therapies Market Size (Million US$) (2017-2027)
Figure North America Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure China Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Intravenous Immune Globulin Therapies Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Intravenous Immune Globulin Therapies Sales by Manufacturer (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Sales Market Share by Manufacturer in 2021
Table Global Intravenous Immune Globulin Therapies Revenue by Manufacturer (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share by Manufacturer in 2021
Table Global Intravenous Immune Globulin Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Intravenous Immune Globulin Therapies Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Intravenous Immune Globulin Therapies Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Intravenous Immune Globulin Therapies Market
Table Key Manufacturers Intravenous Immune Globulin Therapies Product Type
Table Mergers & Acquisitions Planning
Table Baxter Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Baxter
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Grifols Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Grifols
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Grifols Recent Development
Table CSL Plasma Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of CSL Plasma
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CSL Plasma Main Business
Table CSL Plasma Recent Development
Table Octapharma Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Octapharma
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Octapharma Main Business
Table Octapharma Recent Development
Table Octapharma Main Business
Table Octapharma Recent Development
Table Biotest Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Biotest
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biotest Main Business
Table Biotest Recent Development
Table Kedrion Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Kedrion
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kedrion Main Business
Table Kedrion Recent Development
Table Kamada Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Kamada
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kamada Main Business
Table Kamada Recent Development
Table China Biologic Products Holdings Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of China Biologic Products Holdings
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table China Biologic Products Holdings Main Business
Table China Biologic Products Holdings Recent Development
Table Hualan Biological Engineering Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Hualan Biological Engineering
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hualan Biological Engineering Main Business
Table Hualan Biological Engineering Recent Development
Table Sichuan Yuanda Shuyang Pharmaceutical Company Profile
Table Intravenous Immune Globulin Therapies Product Introduction, Application and Specification of Sichuan Yuanda Shuyang Pharmaceutical
Table Intravenous Immune Globulin Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sichuan Yuanda Shuyang Pharmaceutical Main Business
Table Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Figure Global Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Revenue and Growth Rate (2017-2022)
Table Global Intravenous Immune Globulin Therapies Sales by Regions (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Sales Market Share by Regions in 2021
Table Global Intravenous Immune Globulin Therapies Revenue by Regions (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share by Regions in 2021
Figure North America Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Figure Europe Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Figure China Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Figure Japan Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Figure Southeast Asia Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Figure Other Regions Intravenous Immune Globulin Therapies Sales and Growth Rate (2017-2022)
Table Global Intravenous Immune Globulin Therapies Sales by Big Type (2017-2022)
Table Global Intravenous Immune Globulin Therapies Sales Market Share by Big Type (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Sales Market Share by Big Type in 2019
Table Global Intravenous Immune Globulin Therapies Revenue by Big Type (2017-2022)
Table Global Intravenous Immune Globulin Therapies Revenue Market Share by Big Type (2017-2022)
Table Global Intravenous Immune Globulin Therapies Revenue Market Share by Big Type in 2019
Figure Global Liquid Form Sales Growth Rate (2017-2022)
Figure Global Liquid Form Price (2017-2022)
Figure Global Lyophilized Powder Form Sales Growth Rate (2017-2022)
Table Global Intravenous Immune Globulin Therapies Sales by Big Application (2017-2022)
Table Global Intravenous Immune Globulin Therapies Sales Market Share by Big Application (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Sales Market Share by Big Application in 2019
Figure Global Immunodeficiency Sales Growth Rate (2017-2022)
Figure Global Autoimmune Disease Sales Growth Rate (2017-2022)
Figure Global Acute Infection Sales Growth Rate (2017-2022)
Figure Global Intravenous Immune Globulin Therapies Sales and Growth Rate (2022-2027)
Figure Global Intravenous Immune Globulin Therapies Revenue and Growth Rate (2022-2027)
Table Global Intravenous Immune Globulin Therapies Sales Forecast by Regions (2022-2027)
Table Global Intravenous Immune Globulin Therapies Market Share Forecast by Regions (2022-2027)
Figure North America Sales Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
Figure Europe Sales Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
Figure China Sales Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
Figure Japan Sales Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
Figure Southeast Asia Sales Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
Figure Other Regions Sales Intravenous Immune Globulin Therapies Market Forecast (2022-2027)
Table Global Intravenous Immune Globulin Therapies Sales Forecast by Type (2022-2027)
Table Global Intravenous Immune Globulin Therapies Market Share Forecast by Type (2022-2027)
Table Global Intravenous Immune Globulin Therapies Sales Forecast by Application (2022-2027)
Table Global Intravenous Immune Globulin Therapies Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous Immune Globulin Therapies
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Intravenous Immune Globulin Therapies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Intravenous Immune Globulin Therapies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Intravenous Immune Globulin Therapies Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Intravenous Immune Globulin Therapies Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Intravenous Immune Globulin Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings